“…Furthermore, from a substudy that investigated the association between a history of vasodilator and blood pressure-lowering drug use and the incidence and progression of early and late AMD, it emerged that oral nitroglycerin (HR, 1.81; 95% CI, 1.14-2.90) was associated with an increased risk of early AMD, whereas oral b-blocking agents treatment was associated with an increased risk of incident exudative AMD [hazard ratio (HR), 1.71; 95% CI, 1.04-2.82], but not pure geographic atrophy (HR, 0.51; 95% CI, 0.20-1.29) or AMD progression (HR, 0.92; 95% CI, 0.67-1.28) over a 20-year period Table 2 [33,34,37,38,40,41,[43][44][45][46][47][48][49][50]58]. The mechanisms leading to the above observations are not easy to understand, especially when we consider that vasoconstriction of the retinal and choroidal vessels seems to be involved in the pathogenesis of AMD, while vasodilators have been used to resolve the vasoconstriction.…”